Online first
Case report
Published online: 2024-01-24

open access

Page views 131
Article views/downloads 122
Get Citation

Connect on Social Media

Connect on Social Media

Eosinophilic fasciitis — a case report

Joanna Zalewska12, Tacjana Barczyńska12, Małgorzata Węgierska12, Daniel Jeka3

Abstract

Eosinophilic fasciitis (EF) is a rare disease. The case of a patient who was treated with immunosuppressive therapy with methotrexate and methylprednisolone was presented. The aetiology of the disease, diagnostic difficulties and treatment were also discussed.

Article available in PDF format

View PDF (Polish) Download PDF file

References

  1. Shulman LE. Diffuse fasciitis with eosinophilia: a new syndrome? Trans Assoc Am Physicians. 1975; 88: 70–86.
  2. Niklas K, Niklas A, Puszczewicz M. Eosinophilic fasciitis. Postępy Higieny i Medycyny Doświadczalnej. 2015; 69: 488–495.
  3. Mazilu D, Boltașiu Tătaru LA, Mardale DA, et al. Eosinophilic Fasciitis: Current and Remaining Challenges. Int J Mol Sci. 2023; 24(3).
  4. Bobrowska-Snarska D, Ostanek L, Brzosko M. [Eosinophilic fasciitis--diagnostic and therapeutic difficulties]. Ann Acad Med Stetin. 2008; 54(2): 47–51.
  5. Bobrowska-Snarska D, Ostanek L, Brzosko M. Fasciitis eosinophilica: personal observations and a review of the literature. Pol Arch Med Wewn. 2007; 117(4): 184–191.
  6. Puszczewicz M, Zimmermann-Górska I, Pietrzak-Kaczmarek H, et al. [Diagnostic problems in eosinophilic fasciitis]. Pol Arch Med Wewn. 2006; 116(2): 777–780.
  7. Ząber K, Niećko UK, Tytoń J, et al. Eozynofilowe zapalenie powięzi. Forum Reumatol. 2020; 6(1): 45–50.
  8. Lebeaux D, Francès C, Barete S, et al. Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients. Rheumatology (Oxford). 2012; 51(3): 557–561.
  9. Macklin M, Yadav S, Jan R, et al. Checkpoint Inhibitor-Associated Scleroderma and Scleroderma Mimics. Pharmaceuticals (Basel). 2023; 16(2).
  10. Ihn H. Eosinophilic fasciitis: From pathophysiology to treatment. Allergol Int. 2019; 68(4): 437–439.
  11. Lan TY, Wang ZH, Kong WP, et al. Eosinophilic fasciitis difficult to differentiate from scleroderma: A case report. World J Clin Cases. 2023; 11(13): 3092–3098.
  12. Mazori DR, Femia AN, Vleugels RA. Eosinophilic Fasciitis: an Updated Review on Diagnosis and Treatment. Curr Rheumatol Rep. 2017; 19(12): 74.
  13. Kucharz EJ, Sierakowski SJ. Zespoły przypominające twardzinę układową wywołane przez czynniki chemiczne. Przegl Lek. 1987; 44: 666–671.
  14. Pinal-Fernandez I, Callejas-Moraga EL, Roade-Tato ML, et al. Groove sign in eosinophilic fasciitis. Lancet. 2014; 384(9956): 1774.
  15. Pinal-Fernandez I, Selva-O Callaghan A, Grau JM. Diagnosis and classification of eosinophilic fasciitis. Autoimmun Rev. 2014; 13(4–5): 379–382.
  16. Samborski W, Żaba R. Zastosowanie dożylnej pulsacyjnej terapii glikokortykosteroidami u chorego na eozynofilowe zapalenie powięzi. Dermatol Klin. 2000; 2: 33–36.